- Home
- JAZZ vs NNN Comparison
JAZZ vs NNN Comparison
Compare JAZZ & NNN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- JAZZ
- NNN
- Stock Information
- Founded
- JAZZ 2003
- NNN 1984
- Country
- JAZZ Ireland
- NNN United States
- Employees
- JAZZ N/A
- NNN N/A
- Industry
- JAZZ Biotechnology: Pharmaceutical Preparations
- NNN Real Estate Investment Trusts
- Sector
- JAZZ Health Care
- NNN Real Estate
- Exchange
- JAZZ Nasdaq
- NNN Nasdaq
- Market Cap
- JAZZ 8.2B
- NNN 7.8B
- IPO Year
- JAZZ 2007
- NNN N/A
- Fundamental
- Price
- JAZZ $141.45
- NNN $40.99
- Analyst Decision
- JAZZ Strong Buy
- NNN Hold
- Analyst Count
- JAZZ 14
- NNN 8
- Target Price
- JAZZ $179.71
- NNN $43.86
- AVG Volume (30 Days)
- JAZZ 739.6K
- NNN 1.4M
- Earning Date
- JAZZ 11-05-2025
- NNN 11-04-2025
- Dividend Yield
- JAZZ N/A
- NNN 5.85%
- EPS Growth
- JAZZ N/A
- NNN N/A
- EPS
- JAZZ N/A
- NNN 2.08
- Revenue
- JAZZ $4,157,832,999.00
- NNN $906,297,000.00
- Revenue This Year
- JAZZ $5.80
- NNN $5.59
- Revenue Next Year
- JAZZ $6.06
- NNN $4.13
- P/E Ratio
- JAZZ N/A
- NNN $19.73
- Revenue Growth
- JAZZ 4.14
- NNN 4.53
- 52 Week Low
- JAZZ $95.49
- NNN $35.80
- 52 Week High
- JAZZ $148.06
- NNN $44.81
- Technical
- Relative Strength Index (RSI)
- JAZZ 61.16
- NNN 46.71
- Support Level
- JAZZ $128.80
- NNN $39.46
- Resistance Level
- JAZZ $144.97
- NNN $41.47
- Average True Range (ATR)
- JAZZ 4.65
- NNN 0.76
- MACD
- JAZZ -0.13
- NNN 0.04
- Stochastic Oscillator
- JAZZ 75.14
- NNN 54.87
About JAZZ Jazz Pharmaceuticals plc (Ireland)
Jazz Pharmaceuticals is an Ireland-domiciled biopharmaceutical firm focused primarily on treatments for sleeping disorders and oncology. Jazz has nine approved drugs across neuroscience and oncology indications; its portfolio includes Xyrem and Xywav for narcolepsy, Zepzelca for the treatment of metastatic small cell lung cancer, Rylaze for acute lymphoblastic leukemia, and Vyxeos for acute myeloid leukemia. In May 2021, Jazz acquired GW Pharmaceuticals and gained its leading product, Epidiolex for the treatment of severe, rare forms of epilepsy.
About NNN NNN REIT Inc.
NNN REIT Inc is a real estate investment trust that invests in and develops properties throughout the United States. The company generates revenue from leasing properties to tenants, including convenience stores, automotive services, fitness centers, theatres, restaurants, and banks. Rents from convenience stores and restaurants contribute the majority proportion of total revenue. The maximum of the company's properties are located in the South and Southeast of the United States.